Concepts (195)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Psychotic Disorders | 21 | 2023 | 2848 | 3.960 |
Why?
|
| Schizophrenia | 20 | 2022 | 6754 | 2.790 |
Why?
|
| Choroid Plexus | 4 | 2023 | 202 | 1.700 |
Why?
|
| Retinal Vessels | 3 | 2022 | 770 | 1.130 |
Why?
|
| Bipolar Disorder | 9 | 2022 | 5060 | 1.030 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 2 | 2016 | 571 | 0.930 |
Why?
|
| Antipsychotic Agents | 4 | 2021 | 3071 | 0.810 |
Why?
|
| Tomography, Optical Coherence | 4 | 2022 | 2494 | 0.790 |
Why?
|
| Hallucinations | 2 | 2022 | 360 | 0.760 |
Why?
|
| Nitric Oxide Synthase Type II | 4 | 2017 | 560 | 0.760 |
Why?
|
| Clozapine | 1 | 2021 | 496 | 0.670 |
Why?
|
| Endophenotypes | 1 | 2020 | 252 | 0.670 |
Why?
|
| Microvessels | 2 | 2022 | 567 | 0.670 |
Why?
|
| Cell Respiration | 1 | 2017 | 208 | 0.600 |
Why?
|
| Neurologic Examination | 1 | 2019 | 959 | 0.580 |
Why?
|
| HSP20 Heat-Shock Proteins | 4 | 2015 | 5 | 0.500 |
Why?
|
| Tourette Syndrome | 1 | 2016 | 391 | 0.490 |
Why?
|
| Schizophrenic Psychology | 1 | 2019 | 1683 | 0.430 |
Why?
|
| Frontal Lobe | 1 | 2018 | 1427 | 0.430 |
Why?
|
| Retina | 2 | 2020 | 2651 | 0.430 |
Why?
|
| Temporal Lobe | 1 | 2018 | 1662 | 0.400 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2018 | 3512 | 0.380 |
Why?
|
| Myocytes, Cardiac | 4 | 2017 | 1645 | 0.370 |
Why?
|
| Cell Survival | 2 | 2017 | 6133 | 0.360 |
Why?
|
| Adenosine Triphosphatases | 1 | 2013 | 900 | 0.340 |
Why?
|
| Brain | 13 | 2023 | 25281 | 0.330 |
Why?
|
| Myocardium | 3 | 2017 | 4943 | 0.310 |
Why?
|
| Mitochondria, Heart | 3 | 2015 | 262 | 0.310 |
Why?
|
| Muscle Proteins | 4 | 2015 | 1235 | 0.310 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2016 | 1570 | 0.310 |
Why?
|
| Cognition | 4 | 2021 | 6109 | 0.310 |
Why?
|
| Interferon-gamma | 1 | 2015 | 3277 | 0.310 |
Why?
|
| Mitochondria | 1 | 2017 | 3642 | 0.240 |
Why?
|
| Inflammation | 2 | 2022 | 10116 | 0.240 |
Why?
|
| Visual Cortex | 2 | 2022 | 1141 | 0.230 |
Why?
|
| Heat-Shock Proteins | 5 | 2015 | 888 | 0.230 |
Why?
|
| Neuroanatomy | 1 | 2022 | 64 | 0.220 |
Why?
|
| Cognition Disorders | 1 | 2016 | 3990 | 0.220 |
Why?
|
| Cell Cycle Proteins | 1 | 2013 | 3511 | 0.210 |
Why?
|
| Humans | 36 | 2023 | 717280 | 0.200 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2020 | 17432 | 0.170 |
Why?
|
| Magnetic Resonance Imaging | 9 | 2023 | 34503 | 0.170 |
Why?
|
| Paresis | 1 | 2019 | 178 | 0.160 |
Why?
|
| DiGeorge Syndrome | 1 | 2019 | 183 | 0.160 |
Why?
|
| Family | 2 | 2020 | 3105 | 0.150 |
Why?
|
| Organ Size | 2 | 2019 | 2308 | 0.150 |
Why?
|
| Cryopreservation | 1 | 2020 | 635 | 0.150 |
Why?
|
| Molecular Chaperones | 4 | 2015 | 759 | 0.150 |
Why?
|
| Gene Deletion | 2 | 2017 | 2834 | 0.150 |
Why?
|
| Adenosine Diphosphate | 1 | 2017 | 442 | 0.150 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2017 | 163 | 0.140 |
Why?
|
| Conversion Disorder | 1 | 2019 | 192 | 0.140 |
Why?
|
| Angiography | 1 | 2022 | 1669 | 0.140 |
Why?
|
| Gyrus Cinguli | 1 | 2021 | 1073 | 0.140 |
Why?
|
| Visual Pathways | 1 | 2020 | 589 | 0.140 |
Why?
|
| Complement System Proteins | 1 | 2019 | 837 | 0.140 |
Why?
|
| Thalamus | 2 | 2021 | 1016 | 0.130 |
Why?
|
| Cardiovascular Agents | 1 | 2021 | 867 | 0.130 |
Why?
|
| Young Adult | 7 | 2022 | 56249 | 0.130 |
Why?
|
| Male | 18 | 2022 | 351399 | 0.130 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2017 | 497 | 0.120 |
Why?
|
| Amygdala | 2 | 2021 | 1273 | 0.120 |
Why?
|
| Oxygen Consumption | 2 | 2017 | 1933 | 0.110 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2022 | 1317 | 0.110 |
Why?
|
| Adult | 9 | 2022 | 212470 | 0.110 |
Why?
|
| NF-kappa B | 4 | 2013 | 2584 | 0.100 |
Why?
|
| Ischemic Preconditioning, Myocardial | 1 | 2011 | 67 | 0.100 |
Why?
|
| Female | 13 | 2022 | 377934 | 0.100 |
Why?
|
| Interleukin-10 | 1 | 2015 | 1211 | 0.100 |
Why?
|
| Phenotype | 4 | 2020 | 16404 | 0.100 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2020 | 1604 | 0.090 |
Why?
|
| Statistics as Topic | 1 | 2016 | 2405 | 0.090 |
Why?
|
| Neuropsychological Tests | 2 | 2021 | 6929 | 0.090 |
Why?
|
| Cells, Cultured | 6 | 2020 | 20097 | 0.090 |
Why?
|
| Mice, Transgenic | 3 | 2017 | 9927 | 0.090 |
Why?
|
| Cardiomegaly | 2 | 2011 | 650 | 0.090 |
Why?
|
| Continuity of Patient Care | 1 | 2016 | 1048 | 0.090 |
Why?
|
| Adolescent | 6 | 2020 | 85143 | 0.090 |
Why?
|
| Hippocampus | 2 | 2021 | 3660 | 0.090 |
Why?
|
| Isoenzymes | 1 | 2013 | 1812 | 0.080 |
Why?
|
| Endothelial Cells | 1 | 2020 | 3433 | 0.080 |
Why?
|
| STAT3 Transcription Factor | 1 | 2011 | 907 | 0.080 |
Why?
|
| Cost-Benefit Analysis | 1 | 2019 | 5268 | 0.080 |
Why?
|
| Oxidative Phosphorylation | 3 | 2015 | 488 | 0.070 |
Why?
|
| Linear Models | 1 | 2016 | 5980 | 0.070 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2016 | 6199 | 0.070 |
Why?
|
| Calcitriol | 1 | 2007 | 308 | 0.070 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2015 | 8600 | 0.070 |
Why?
|
| Blood-Brain Barrier | 2 | 2022 | 1003 | 0.070 |
Why?
|
| Acute Disease | 1 | 2015 | 7177 | 0.070 |
Why?
|
| Receptors, Calcitriol | 1 | 2007 | 348 | 0.070 |
Why?
|
| Longitudinal Studies | 2 | 2021 | 13613 | 0.070 |
Why?
|
| Protease Inhibitors | 1 | 2008 | 827 | 0.060 |
Why?
|
| Logistic Models | 1 | 2019 | 13605 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2013 | 2593 | 0.060 |
Why?
|
| Mice | 7 | 2017 | 81128 | 0.060 |
Why?
|
| Combined Modality Therapy | 1 | 2016 | 8925 | 0.060 |
Why?
|
| Gene Expression | 1 | 2017 | 8013 | 0.060 |
Why?
|
| Nitric Oxide | 1 | 2012 | 2127 | 0.060 |
Why?
|
| Cerebral Cortex | 1 | 2019 | 5728 | 0.060 |
Why?
|
| Genetic Variation | 1 | 2018 | 6664 | 0.060 |
Why?
|
| Hypertension | 1 | 2022 | 8285 | 0.060 |
Why?
|
| Rats | 3 | 2015 | 25092 | 0.060 |
Why?
|
| Coronary Artery Disease | 1 | 2021 | 6313 | 0.050 |
Why?
|
| Fovea Centralis | 1 | 2022 | 112 | 0.050 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2019 | 4081 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2019 | 21811 | 0.050 |
Why?
|
| Animals | 8 | 2022 | 170894 | 0.050 |
Why?
|
| Collagen Type IV | 1 | 2020 | 136 | 0.050 |
Why?
|
| Ventricular Remodeling | 1 | 2008 | 1273 | 0.050 |
Why?
|
| Schizophrenia, Paranoid | 1 | 2020 | 103 | 0.050 |
Why?
|
| Myocardial Ischemia | 1 | 2011 | 2136 | 0.050 |
Why?
|
| Models, Biological | 1 | 2017 | 9892 | 0.050 |
Why?
|
| Basement Membrane | 1 | 2020 | 359 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2016 | 9000 | 0.050 |
Why?
|
| Spin Labels | 1 | 2020 | 314 | 0.040 |
Why?
|
| Cerebrospinal Fluid | 1 | 2022 | 555 | 0.040 |
Why?
|
| Leukemia | 1 | 2007 | 1529 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2018 | 15600 | 0.040 |
Why?
|
| Heart | 1 | 2012 | 4332 | 0.040 |
Why?
|
| Prognosis | 1 | 2019 | 29226 | 0.040 |
Why?
|
| Fluorescein Angiography | 1 | 2022 | 893 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 39302 | 0.040 |
Why?
|
| Monocytes | 1 | 2007 | 2657 | 0.040 |
Why?
|
| Electric Impedance | 1 | 2020 | 655 | 0.040 |
Why?
|
| Fibronectins | 1 | 2020 | 725 | 0.040 |
Why?
|
| Coculture Techniques | 1 | 2020 | 1377 | 0.040 |
Why?
|
| Heart Failure | 2 | 2011 | 10185 | 0.040 |
Why?
|
| Motion Perception | 1 | 2020 | 374 | 0.040 |
Why?
|
| Nerve Fibers | 1 | 2020 | 709 | 0.040 |
Why?
|
| Ventricular Function, Left | 1 | 2008 | 3433 | 0.040 |
Why?
|
| Physical Therapy Modalities | 1 | 2019 | 527 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2022 | 1292 | 0.030 |
Why?
|
| Membrane Transport Proteins | 1 | 2020 | 1024 | 0.030 |
Why?
|
| Back Pain | 1 | 2019 | 550 | 0.030 |
Why?
|
| Memory, Short-Term | 1 | 2021 | 940 | 0.030 |
Why?
|
| Mitochondrial Membranes | 1 | 2015 | 167 | 0.030 |
Why?
|
| Neovascularization, Physiologic | 1 | 2020 | 1423 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2015 | 39891 | 0.030 |
Why?
|
| Middle Aged | 3 | 2022 | 215054 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2020 | 1789 | 0.030 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2012 | 249 | 0.030 |
Why?
|
| Nitroarginine | 1 | 2011 | 68 | 0.030 |
Why?
|
| Headache | 1 | 2019 | 1152 | 0.030 |
Why?
|
| Circadian Rhythm | 1 | 2022 | 2553 | 0.020 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2020 | 2198 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2022 | 3709 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 23409 | 0.020 |
Why?
|
| Cerebrovascular Circulation | 1 | 2020 | 2755 | 0.020 |
Why?
|
| Psychotherapy | 1 | 2019 | 1567 | 0.020 |
Why?
|
| Protein Transport | 1 | 2015 | 2066 | 0.020 |
Why?
|
| Transgenes | 1 | 2012 | 1021 | 0.020 |
Why?
|
| Collagen Type III | 1 | 2008 | 91 | 0.020 |
Why?
|
| Executive Function | 1 | 2017 | 1321 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2019 | 2345 | 0.020 |
Why?
|
| Cell Differentiation | 2 | 2020 | 11762 | 0.020 |
Why?
|
| Ligation | 1 | 2008 | 479 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2012 | 2049 | 0.020 |
Why?
|
| Child | 3 | 2020 | 74388 | 0.020 |
Why?
|
| HL-60 Cells | 1 | 2007 | 372 | 0.020 |
Why?
|
| Attention | 1 | 2017 | 2414 | 0.020 |
Why?
|
| Indicators and Reagents | 1 | 2007 | 482 | 0.020 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2008 | 481 | 0.020 |
Why?
|
| Sleep | 1 | 2021 | 4222 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2011 | 1593 | 0.020 |
Why?
|
| Collagen Type I | 1 | 2008 | 577 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 19537 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2020 | 10802 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2012 | 2147 | 0.020 |
Why?
|
| Ischemia | 1 | 2012 | 1955 | 0.010 |
Why?
|
| Myocardial Contraction | 1 | 2008 | 1649 | 0.010 |
Why?
|
| Collagen | 1 | 2011 | 2694 | 0.010 |
Why?
|
| Oligopeptides | 1 | 2008 | 1275 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2011 | 3018 | 0.010 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2008 | 1472 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 2007 | 2336 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2011 | 3217 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 2007 | 3249 | 0.010 |
Why?
|
| Swine | 1 | 2011 | 5821 | 0.010 |
Why?
|
| Aorta | 1 | 2008 | 2114 | 0.010 |
Why?
|
| Coronary Vessels | 1 | 2011 | 2988 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 4935 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2007 | 3022 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2007 | 5542 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2021 | 51277 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2011 | 15258 | 0.010 |
Why?
|
| Stroke Volume | 1 | 2008 | 4589 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2011 | 9532 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2008 | 13301 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2007 | 7952 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2008 | 8582 | 0.010 |
Why?
|
| Apoptosis | 1 | 2008 | 10119 | 0.010 |
Why?
|
| Risk Factors | 1 | 2017 | 70863 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2008 | 18353 | 0.010 |
Why?
|
| Time Factors | 1 | 2008 | 41094 | 0.000 |
Why?
|
Concepts
(195)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(22)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_